Cai Song Selected Research

Parkinson Disease (Parkinson's Disease)

1/2022	Potential treatment of Parkinson's disease with omega-3 polyunsaturated fatty acids.
3/2013	ω-3 fatty acid eicosapentaenoic acid attenuates MPP+-induced neurodegeneration in fully differentiated human SH-SY5Y and primary mesencephalic cells.
12/2010	Ethyl-eicosapentaenoate modulates changes in neurochemistry and brain lipids induced by parkinsonian neurotoxin 1-methyl-4-phenylpyridinium in mouse brain slices.
8/2009	Behavior, neurotransmitters and inflammation in three regimens of the MPTP mouse model of Parkinson's disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Cai Song Research Topics

Disease

22	Inflammation (Inflammations) 01/2024 - 03/2004
20	Neuroinflammatory Diseases 03/2024 - 04/2011
11	Alzheimer Disease (Alzheimer's Disease) 08/2020 - 10/2007
7	Neurodegenerative Diseases (Neurodegenerative Disease) 02/2022 - 10/2007
5	Cognitive Dysfunction 07/2023 - 06/2004
4	Anhedonia 03/2024 - 03/2003
4	Schizophrenia (Dementia Praecox) 01/2023 - 10/2007
4	Parkinson Disease (Parkinson's Disease) 01/2022 - 08/2009
4	Pain (Aches) 01/2018 - 08/2009
3	Memory Disorders (Memory Loss) 04/2022 - 02/2010
3	Neoplasms (Cancer) 01/2022 - 01/2017
2	Body Weight (Weight, Body) 01/2022 - 03/2020
2	Lung Neoplasms (Lung Cancer) 01/2022 - 01/2020
2	Dementia (Dementias) 01/2022 - 01/2013
2	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2021 - 12/2020
2	Stroke (Strokes) 01/2021 - 05/2013
2	Brain Diseases (Brain Disorder) 01/2016 - 12/2015
2	Necrosis 10/2015 - 06/2006
2	Seasonal Affective Disorder 10/2015 - 01/2004
2	Wounds and Injuries (Trauma) 04/2015 - 06/2012
1	Chronic Renal Insufficiency 04/2022
1	Cushing Syndrome 01/2021
1	Pathologic Processes 01/2021
1	Ischemic Stroke 12/2020
1	Cardiovascular Diseases (Cardiovascular Disease) 12/2020
1	Infarction (Infarctions) 12/2020
1	Ischemia 12/2020
1	Type 2 Diabetes Mellitus (MODY) 10/2020
1	Substance-Related Disorders (Drug Abuse) 01/2018
1	Neoplasm Metastasis (Metastasis) 01/2017
1	Hepatocellular Carcinoma (Hepatoma) 01/2017

Drug/Important Bio-Agent (IBA)

12	Neurotransmitter Agents (Neurotransmitter)IBA 01/2024 - 01/2004
12	CytokinesIBA 01/2022 - 06/2004
11	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2024 - 05/2008
11	Nerve Growth Factors (Neurotrophins)IBA 01/2022 - 02/2010
9	InterleukinsIBA 03/2024 - 06/2004
9	Eicosapentaenoic AcidIBA 07/2023 - 03/2004
6	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 01/2023 - 03/2004
5	Antidepressive Agents (Antidepressants)IBA 03/2024 - 03/2004
5	Neuroprotective AgentsIBA 02/2022 - 10/2007
4	Interleukin-6 (Interleukin 6)IBA 01/2023 - 12/2008
4	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2022 - 08/2018
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2024 - 06/2006
3	Sucrose (Saccharose)IBA 03/2024 - 03/2020
3	Docosahexaenoic AcidsIBA 07/2023 - 01/2016
3	CorticosteroneIBA 01/2023 - 01/2019
3	GlucocorticoidsIBA 01/2019 - 02/2010
3	Acetylcholine (Acetylcholine Chloride)FDA Link 11/2017 - 02/2010
3	Nerve Growth Factor (NGF)IBA 03/2017 - 01/2009
3	Fatty Acids (Saturated Fatty Acids)IBA 01/2016 - 05/2008
3	Arginine Vasopressin (Argipressin)IBA 04/2010 - 08/2009
3	eicosapentaenoic acid ethyl esterIBA 02/2010 - 03/2004
2	Interleukin-10 (Interleukin 10)IBA 01/2022 - 06/2006
2	Oxidants (Oxidizing Agents)IBA 10/2021 - 03/2020
2	CholesterolIBA 10/2020 - 01/2019
2	Cholinergic Agents (Cholinergics)IBA 08/2020 - 02/2010
2	AcetylcholinesteraseIBA 08/2020 - 11/2017
2	AntioxidantsIBA 11/2017 - 01/2016
2	Amyloid (Amyloid Fibrils)IBA 11/2017 - 10/2012
2	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 11/2012 - 10/2012
2	SodiumIBA 09/2009 - 08/2009
2	Glutamic Acid (Glutamate)FDA Link 09/2009 - 08/2009
1	Mitogen-Activated Protein KinasesIBA 03/2024
1	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 01/2024
1	EnzymesIBA 01/2024
1	Serotonin (5 Hydroxytryptamine)IBA 01/2023
1	Interleukin-17 (Interleukin 17)IBA 01/2023
1	RNA (Ribonucleic Acid)IBA 04/2022
1	Adenine FDA LinkGeneric 04/2022
1	fucoidanIBA 04/2022
1	diazonaphthalenedisulfonic acid (NDS)IBA 02/2022
1	Aluminum ChlorideIBA 02/2022
1	butyrolactone IIBA 02/2022
1	SynucleinsIBA 01/2022
1	SmokeIBA 01/2022
1	docosapentaenoic acidIBA 10/2021
1	p38 Mitogen-Activated Protein KinasesIBA 10/2021
1	NF-E2-Related Factor 2IBA 01/2021
1	1- (2- cyano- 3,12- dioxooleana- 1,9- dien- 28- oyl) imidazoleIBA 01/2021
1	stachydrineIBA 12/2020
1	Glucose (Dextrose)FDA LinkGeneric 10/2020
1	DiketopiperazinesIBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2020
1	NPI 2358IBA 01/2020
1	Minocycline (Cyclops)FDA LinkGeneric 01/2019
1	gamma-Aminobutyric Acid (GABA)IBA 01/2019
1	Mifepristone (RU 486)FDA Link 01/2018
1	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 01/2018
1	EndocannabinoidsIBA 01/2018
1	Opioid Analgesics (Opioids)IBA 01/2018
1	MetalsIBA 11/2017
1	CopperIBA 11/2017
1	ChitosanIBA 11/2017
1	IonsIBA 11/2017
1	oligochitosanIBA 11/2017
1	Peptides (Polypeptides)IBA 01/2017
1	Cadherins (E-Cadherin)IBA 01/2017
1	Amyloid beta-PeptidesIBA 01/2017
1	Angiogenesis InhibitorsIBA 01/2017